|
|
Program Overview:
The faculty will discuss data from important late breaking clinical studies presented at the recent annual scientific sessions of American Heart Association (AHA) 2011 in Orlando, FL. This learning activity aims to provide a background and context for the presentation of these new data so that learners will be able to prepare to assimilate this data into their clinical practice.
Click Here to access this CME Program
|
|
Release Date:
January 9, 2012
|
| |
Expiration Date:
June 9, 2012 |
| |
Estimated Time:
1.0 hour |
|
|
Program Overview:
The faculty will discuss late breaking data from important late breaking clinical studies presented at the recent Transcatheter Cardiovascular Therapeutics scientific symposium in San Francisco, CA. This learning activity aims to provide a background and context for the presentation of these new data so that learners will be able to prepare to assimilate this data into their clinical practice.
Click Here to access this CME Program
|
|
Release Date:
January 9, 2011
|
| |
Expiration Date:
June 9, 2012 |
| |
Estimated Time:
1.0 hour |
|
|
Program Overview:
This program addresses the educational need to enhance understanding of the clinical risks and benefits of these new agents. With new guidelines for the management of PCI published by the American College of Cardiology (ACC) and American Heart Association (AHA) in early 2008, the precise application of evidence-based therapy has the potential to improve clinical outcomes for patients undergoing PCI and stenting.
Click Here to access this CME Program
|
|
Release Date:
December 15, 2011
|
| |
Expiration Date:
June 15, 2012 |
| |
Estimated Time:
1.5 hours |
|
|
Program Overview:
A national panel of cardiology experts, led by A. Michael Lincoff, MD, of the Cleveland Clinic, looks at glucose regulation, insulin resistance, and lipid modification as part of an overall strategy for reducing cardiovascular risk in the setting of diabetes and acute coronary syndrome.
Click Here to access this CME Program
|
|
Release Date:
December 7, 2011
|
| |
Expiration Date:
December 7, 2013 |
| |
Estimated Time:
2.5 hours |
|
|
Program Overview:
Deepak Bhatt, MD, of Harvard Medical School, leads a national panel of experts reviewing the latest antithrombotic interventions in high risk ACS, with a focus on novel anticoagulation strategies in the setting of PCI. They ask the questions, “Where Are The Science, Data, and Clinical Trials Taking Us?”
Click Here to access this CME Program
|
|
Release Date:
December1, 2011
|
| |
Expiration Date:
December1, 2013 |
| |
Estimated Time:
2.5 hours |
|
|
Program Overview:
This symposium will review the wide spectrum of myocardial ischemia from diagnosis to management. An emphasis will be placed on ischemia as evaluated pre- and post-revascularization. An overview will be provided of the multiple pathophysiological characteristics and how they may affect patient outcomes, including myocardial viability, preprocedural ischemia, and plaque composition. The concept of vulnerable plaque and its consequences will be discussed. The importance of complete revascularization will be reviewed and compared to incomplete revascularization. The management of the later will be discussed with introduction of the RIVER-PCI study.
Click Here to access this CME Program
|
|
Release Date:
December 1, 2011
|
| |
Expiration Date:
June 1, 2012 |
| |
Estimated Time:
1.0 hour |
|
|
Program Overview:
The faculty will discuss late breaking data from important late breaking clinical studies presented at the recent annual scientific sessions of Transcatheter Cardiovascular Therapeutics (TCT) 2011 in San Francisco, CA. This learning activity aims to provide a background and context for the presentation of these new data so that learners will be able to prepare to assimilate this data into their clinical practice.
Click Here to access this CME Program
|
|
Release Date:
November 30, 2011
|
| |
Expiration Date:
May 30, 2012 |
| |
Estimated Time:
1.0 hour |
|
|
Program Overview:
Herzel Gerstein, MD, of McMaster University, leads a national panel of experts in reviewing the role of early insulin therapy for optimizing cardiovascular risk reduction across the dysglycemic continuum for type 2 diabetes. A close look at what the landmark outcome trials teach us about cardioprotection in the diabetic patient.
Click Here to access this CME Program
|
|
Release Date:
November 28, 2011
|
| |
Expiration Date:
November 28, 2013 |
| |
Estimated Time:
2.5 hours |
|
|
Program Overview:
The most comprehensive multimedia CME resource for SPAF. The “Best and the Brightest” address the trickiest and toughest questions, issues and clinical dilemmas in stroke prevention in Atrial Fibrillation.
Click Here to access this CME Program
|
|
Release Date:
November 28, 2011
|
| |
Expiration Date:
November 28, 2013 |
| |
Estimated Time:
6.0 hours |
|
|
Program Overview:
Those attending will be exposed to a discussion of late-breaking data from the most important Interventionally-focused trials presented at the 2011 European Society of Cardiology Congress. This learning activity aims to provide a background and context for the presentation of these new data so that learners will be able to prepare to assimilate this data into their clinical practice. Examples of trials to be covered include a trial examining the duration of clopidogrel therapy following PCI (PRODIGY), a trial examining the utility of novel anticoagulants in patients with acute coronary syndromes (RUBY-1), two trials examining novel drug eluting stents in clinical practice, and a trial investigating the use of intra-aortic balloon pump counterpulsation as adjunctive hemodynamic support in acute myocardial infarction.
Click Here to access this CME Program
|
|
Release Date:
September 13, 2011
|
| |
Expiration Date:
March 13, 2012 |
| |
Estimated Time:
1.0 hour |
|
|
Program Overview:
In this webcast, we will review the basic principles of the DCB technology, technologies under development and current clinical data available today. A panel of experts will discuss the potential clinical applications, challenges, and opportunities of this technology in the current market. Also, the discussion will cover the main technical components of the technology focusing on key aspects related to coating formulation, carrier, and drug selection. In addition, the specific potential value, challenges, and new improvements of these formulations will be discussed.
Click Here to access this CME Program
|
|
Release Date:
August 8, 2011
|
| |
Expiration Date:
February 8, 2012 |
| |
Estimated Time:
1.0 hour |
|
|
Program Overview:
Distinguished presenter Gerald V. Naccarelli, MD, Professor of Medicine and Chief, Division of Cardiology at Penn State Heart and Vascular Institute, examines risk stratification and pharmacologic management strategies for optimizing rhythm control for patients with new onset atrial fibrillation.
Click Here to access this CME Program
|
|
Release Date:
February 28, 2011
|
| |
Expiration Date:
February 28, 2013 |
| |
Estimated Time:
2.0 hours |
|
|
Program Overview:
This activity serves as a primer for practicing physicians with an interest in peripheral arterial disease by providing an overview of the causes, syndromes, and appropriate methods for treating the disease with an emphasis on technical aspects of endovascular approaches.
Click Here to access this CME Program
|
|
Release Date:
January 12, 2011
|
| |
Expiration Date:
January 12, 2012 |
| |
Estimated Time:
1.5 hours |
|
|
Program Overview:
Deepak Bhatt, MD, of Harvard Medical School and the VA Boston Healthcare System, examines the evidence, guidelines, and recent studies on oral antiplatelet therapy in the front lines of cardiovascular practice, with a special emphasis on the myths and truths of drug interactions with PPIs.
Click Here to access this CME Program
|
|
Release Date:
April 10, 2010
|
| |
Expiration Date:
April 10, 2012 |
| |
Estimated Time:
2.0 hours |
|
|
Program Overview:
Peter Libby, MD, FACC, Chief of Cardiovascular Medicine at Brigham and Women’s Hospital, chairs an expert faculty as they study the latest developments and landscape changes in atrial fibrillation, focusing on emerging strategies for stroke prevention.
Click Here to access this CME Program
|
|
Release Date:
April 1, 2010
|
| |
Expiration Date:
April 1, 2012 |
| |
Estimated Time:
3.0 hours |
|